Everdime Technologies, Inc.
RGST · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $31 | $66 | $229 | $8 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $31 | $66 | $229 | $8 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -66.9% | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 26.9% | 68.6% | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -74.5% | -21.4% | – | – |
| Net Income | -$1 | -$0 | -$2 | -$0 |
| % Margin | -1,091.3% | -21.9% | – | – |
| EPS Diluted | -0.006 | -0 | -0.015 | -0 |
| % Growth | -1,500% | 97.4% | -7,450% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |